Sanofi India Limited 3.72 % Pharmaceuticals

Trend Analysis


Support and Resistance Levels Analysis
The current close value 6538.2 is between the support and resistance channel of 6396 and 6775. The stock has a Observe Signal , 6396 becomes a critical support to stop the fall and 6775 is a immediate resistance on the upside. Note that in case of a Observe Signal, the stocks tends to change trends. This happens mostly near the support and resistance levels.
Technical Indicators (3 Month duration)
Exponential Moving average 6476.7
MACD value 149.0
Price range 5123.50 to 6649.00
Volume range 4607 to 30031
Support & Resistance 6396, 6775
Stock Performance
Six Months 28.2%
Five Months35.1%
Four Months31.1%
Three Months26.0%
Two Months12.2%
One Month7.3%
Last Six Months


Last Five Months


Last Four Months


Last Three Months


Last Two Months


Last One Month


Today's Price Range
3 Month Price Range
About Sanofi India Limited
Sanofi India Limited is an India-based pharmaceutical company. The Company provides medicines for the treatment of patients in several therapeutic areas: cardiology, thrombosis, oncology, diabetes, central nervous system, internal medicine and consumer healthcare. The Company is engaged in diverse activities, such as producing active pharmaceutical ingredients (API), manufacturing and handling formulations and exporting. The Company has two manufacturing facilities at Ankleshwar, Gujarat (chemistry and pharmaceuticals) and at Verna, Goa (pharmaceuticals). The Company's products include Cardace, Cardace am, Cardace H, Lasilactone, Lasix, Sitelodip, Sitelol AM, Sitelol XR, Sitestat, Sitestat F, Telsite, Tesite H, Telsite AM, Clexane, , Amaryl, Amaryl M, Apidra, Cetapin XR, Daonil, Daonil M, Semi-Daonil, Insuman, Lantus, Trental 400, Glimsite, Glimsite M, Glimsite MP, Mesite XR, Rejusite, Vogsite MD, Granocyte, Taxotere, Allegra, Allegra Suspension, Avil and Cosavil Flu, among others.
See stocks similar to Sanofi India Limited in Pharmaceuticals

Sanofi India Limited has Observe Signal. What is your opinion on it?

{ }